[Biomarkers for toxicity and metabolic abnormalities of the main severe poisonings. Clinical and toxicologic symptoms. Conservative determination].
Identifieur interne : 000354 ( PubMed/Corpus ); précédent : 000353; suivant : 000355[Biomarkers for toxicity and metabolic abnormalities of the main severe poisonings. Clinical and toxicologic symptoms. Conservative determination].
Auteurs : J-P Goullé ; M. Lhermitte ; M. Bartholi ; J-C Boyer ; B. Capolaghi ; C. Charlier ; V. Danel ; G. Desch ; A. Feuillu ; B. Flouvat ; D. Mathieu ; P. Nisse ; N. Sadeg ; A. SzymanowiczSource :
- Annales de biologie clinique [ 0003-3898 ]
English descriptors
- KwdEn :
- MESH :
- chemical , analysis : Biomarkers.
- diagnosis : Metabolic Diseases, Poisoning.
- methods : Clinical Chemistry Tests.
- Humans, Severity of Illness Index.
Abstract
The members of the joint group "Toxicology and Clinical Biology" of the French Society of Clinical Biology (SFBC), the French Society of Analytical Toxicology (SFTA), and the Society of Clinical Toxicology (STC), suggest guidelines to meet the requirements of clinical biologists who are not specialized in toxicology. Based on good laboratory practice they propose a number of guidelines. Three synthetic tables have been established. They are not only toxicity biomarkers and metabolic disorders associated with the main severe intoxications, but also clinical signs that are observed during these intoxications, finally biological sampling as a precautionary measure. The table also takes into account approximately fifty xenobiotics: main clinical signs emergency, identification or quantification of the suspected product, useful biological markers, therapeutic, quantitations necessary to take into consideration patient care, and poison antidotes, are described. Recommendations regarding medical and forensic techniques are also proposed by the group. It is also necessary to collect and store biological samples when the individual patients are in charge. These samples will be analyzed or not depending on the individual case history.
PubMed: 12915351
Links to Exploration step
pubmed:12915351Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Biomarkers for toxicity and metabolic abnormalities of the main severe poisonings. Clinical and toxicologic symptoms. Conservative determination].</title>
<author><name sortKey="Goulle, J P" sort="Goulle, J P" uniqKey="Goulle J" first="J-P" last="Goullé">J-P Goullé</name>
<affiliation><nlm:affiliation>Laboratoire de pharmacocinétique et de toxicologie cliniques GH, Le Havre.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Lhermitte, M" sort="Lhermitte, M" uniqKey="Lhermitte M" first="M" last="Lhermitte">M. Lhermitte</name>
</author>
<author><name sortKey="Bartholi, M" sort="Bartholi, M" uniqKey="Bartholi M" first="M" last="Bartholi">M. Bartholi</name>
</author>
<author><name sortKey="Boyer, J C" sort="Boyer, J C" uniqKey="Boyer J" first="J-C" last="Boyer">J-C Boyer</name>
</author>
<author><name sortKey="Capolaghi, B" sort="Capolaghi, B" uniqKey="Capolaghi B" first="B" last="Capolaghi">B. Capolaghi</name>
</author>
<author><name sortKey="Charlier, C" sort="Charlier, C" uniqKey="Charlier C" first="C" last="Charlier">C. Charlier</name>
</author>
<author><name sortKey="Danel, V" sort="Danel, V" uniqKey="Danel V" first="V" last="Danel">V. Danel</name>
</author>
<author><name sortKey="Desch, G" sort="Desch, G" uniqKey="Desch G" first="G" last="Desch">G. Desch</name>
</author>
<author><name sortKey="Feuillu, A" sort="Feuillu, A" uniqKey="Feuillu A" first="A" last="Feuillu">A. Feuillu</name>
</author>
<author><name sortKey="Flouvat, B" sort="Flouvat, B" uniqKey="Flouvat B" first="B" last="Flouvat">B. Flouvat</name>
</author>
<author><name sortKey="Mathieu, D" sort="Mathieu, D" uniqKey="Mathieu D" first="D" last="Mathieu">D. Mathieu</name>
</author>
<author><name sortKey="Nisse, P" sort="Nisse, P" uniqKey="Nisse P" first="P" last="Nisse">P. Nisse</name>
</author>
<author><name sortKey="Sadeg, N" sort="Sadeg, N" uniqKey="Sadeg N" first="N" last="Sadeg">N. Sadeg</name>
</author>
<author><name sortKey="Szymanowicz, A" sort="Szymanowicz, A" uniqKey="Szymanowicz A" first="A" last="Szymanowicz">A. Szymanowicz</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="????"><PubDate><MedlineDate>2003 Jul-Aug</MedlineDate>
</PubDate>
</date>
<idno type="RBID">pubmed:12915351</idno>
<idno type="pmid">12915351</idno>
<idno type="wicri:Area/PubMed/Corpus">000354</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Biomarkers for toxicity and metabolic abnormalities of the main severe poisonings. Clinical and toxicologic symptoms. Conservative determination].</title>
<author><name sortKey="Goulle, J P" sort="Goulle, J P" uniqKey="Goulle J" first="J-P" last="Goullé">J-P Goullé</name>
<affiliation><nlm:affiliation>Laboratoire de pharmacocinétique et de toxicologie cliniques GH, Le Havre.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Lhermitte, M" sort="Lhermitte, M" uniqKey="Lhermitte M" first="M" last="Lhermitte">M. Lhermitte</name>
</author>
<author><name sortKey="Bartholi, M" sort="Bartholi, M" uniqKey="Bartholi M" first="M" last="Bartholi">M. Bartholi</name>
</author>
<author><name sortKey="Boyer, J C" sort="Boyer, J C" uniqKey="Boyer J" first="J-C" last="Boyer">J-C Boyer</name>
</author>
<author><name sortKey="Capolaghi, B" sort="Capolaghi, B" uniqKey="Capolaghi B" first="B" last="Capolaghi">B. Capolaghi</name>
</author>
<author><name sortKey="Charlier, C" sort="Charlier, C" uniqKey="Charlier C" first="C" last="Charlier">C. Charlier</name>
</author>
<author><name sortKey="Danel, V" sort="Danel, V" uniqKey="Danel V" first="V" last="Danel">V. Danel</name>
</author>
<author><name sortKey="Desch, G" sort="Desch, G" uniqKey="Desch G" first="G" last="Desch">G. Desch</name>
</author>
<author><name sortKey="Feuillu, A" sort="Feuillu, A" uniqKey="Feuillu A" first="A" last="Feuillu">A. Feuillu</name>
</author>
<author><name sortKey="Flouvat, B" sort="Flouvat, B" uniqKey="Flouvat B" first="B" last="Flouvat">B. Flouvat</name>
</author>
<author><name sortKey="Mathieu, D" sort="Mathieu, D" uniqKey="Mathieu D" first="D" last="Mathieu">D. Mathieu</name>
</author>
<author><name sortKey="Nisse, P" sort="Nisse, P" uniqKey="Nisse P" first="P" last="Nisse">P. Nisse</name>
</author>
<author><name sortKey="Sadeg, N" sort="Sadeg, N" uniqKey="Sadeg N" first="N" last="Sadeg">N. Sadeg</name>
</author>
<author><name sortKey="Szymanowicz, A" sort="Szymanowicz, A" uniqKey="Szymanowicz A" first="A" last="Szymanowicz">A. Szymanowicz</name>
</author>
</analytic>
<series><title level="j">Annales de biologie clinique</title>
<idno type="ISSN">0003-3898</idno>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Biomarkers (analysis)</term>
<term>Clinical Chemistry Tests (methods)</term>
<term>Humans</term>
<term>Metabolic Diseases (diagnosis)</term>
<term>Poisoning (diagnosis)</term>
<term>Severity of Illness Index</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Biomarkers</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Metabolic Diseases</term>
<term>Poisoning</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Clinical Chemistry Tests</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Severity of Illness Index</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The members of the joint group "Toxicology and Clinical Biology" of the French Society of Clinical Biology (SFBC), the French Society of Analytical Toxicology (SFTA), and the Society of Clinical Toxicology (STC), suggest guidelines to meet the requirements of clinical biologists who are not specialized in toxicology. Based on good laboratory practice they propose a number of guidelines. Three synthetic tables have been established. They are not only toxicity biomarkers and metabolic disorders associated with the main severe intoxications, but also clinical signs that are observed during these intoxications, finally biological sampling as a precautionary measure. The table also takes into account approximately fifty xenobiotics: main clinical signs emergency, identification or quantification of the suspected product, useful biological markers, therapeutic, quantitations necessary to take into consideration patient care, and poison antidotes, are described. Recommendations regarding medical and forensic techniques are also proposed by the group. It is also necessary to collect and store biological samples when the individual patients are in charge. These samples will be analyzed or not depending on the individual case history.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">12915351</PMID>
<DateCreated><Year>2003</Year>
<Month>8</Month>
<Day>13</Day>
</DateCreated>
<DateCompleted><Year>2003</Year>
<Month>12</Month>
<Day>23</Day>
</DateCompleted>
<DateRevised><Year>2015</Year>
<Month>11</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0003-3898</ISSN>
<JournalIssue CitedMedium="Print"><Volume>61</Volume>
<Issue>4</Issue>
<PubDate><MedlineDate>2003 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Annales de biologie clinique</Title>
<ISOAbbreviation>Ann. Biol. Clin. (Paris)</ISOAbbreviation>
</Journal>
<ArticleTitle>[Biomarkers for toxicity and metabolic abnormalities of the main severe poisonings. Clinical and toxicologic symptoms. Conservative determination].</ArticleTitle>
<Pagination><MedlinePgn>421-33</MedlinePgn>
</Pagination>
<Abstract><AbstractText>The members of the joint group "Toxicology and Clinical Biology" of the French Society of Clinical Biology (SFBC), the French Society of Analytical Toxicology (SFTA), and the Society of Clinical Toxicology (STC), suggest guidelines to meet the requirements of clinical biologists who are not specialized in toxicology. Based on good laboratory practice they propose a number of guidelines. Three synthetic tables have been established. They are not only toxicity biomarkers and metabolic disorders associated with the main severe intoxications, but also clinical signs that are observed during these intoxications, finally biological sampling as a precautionary measure. The table also takes into account approximately fifty xenobiotics: main clinical signs emergency, identification or quantification of the suspected product, useful biological markers, therapeutic, quantitations necessary to take into consideration patient care, and poison antidotes, are described. Recommendations regarding medical and forensic techniques are also proposed by the group. It is also necessary to collect and store biological samples when the individual patients are in charge. These samples will be analyzed or not depending on the individual case history.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Goullé</LastName>
<ForeName>J-P</ForeName>
<Initials>JP</Initials>
<AffiliationInfo><Affiliation>Laboratoire de pharmacocinétique et de toxicologie cliniques GH, Le Havre.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lhermitte</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Bartholi</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Boyer</LastName>
<ForeName>J-C</ForeName>
<Initials>JC</Initials>
</Author>
<Author ValidYN="Y"><LastName>Capolaghi</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y"><LastName>Charlier</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Danel</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y"><LastName>Desch</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y"><LastName>Feuillu</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Flouvat</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y"><LastName>Mathieu</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y"><LastName>Nisse</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y"><LastName>Sadeg</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y"><LastName>Szymanowicz</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><CollectiveName>Groupe de travail pluridisciplinaire SFBC-SFTA-STC < Toxicologie et biologie clinique ></CollectiveName>
</Author>
</AuthorList>
<Language>FRE</Language>
<PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Biomarqueurs de toxicité et anomalies métaboliques dans les principales intoxications graves. Symptomatologie clinique et toxique. Le prélèvement conservatoire.</VernacularTitle>
</Article>
<MedlineJournalInfo><Country>France</Country>
<MedlineTA>Ann Biol Clin (Paris)</MedlineTA>
<NlmUniqueID>2984690R</NlmUniqueID>
<ISSNLinking>0003-3898</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019963" MajorTopicYN="N">Clinical Chemistry Tests</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008659" MajorTopicYN="N">Metabolic Diseases</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011041" MajorTopicYN="N">Poisoning</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2002</Year>
<Month>Nov</Month>
<Day>8</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2002</Year>
<Month>Dec</Month>
<Day>23</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2003</Year>
<Month>8</Month>
<Day>14</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2003</Year>
<Month>12</Month>
<Day>24</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2003</Year>
<Month>8</Month>
<Day>14</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">12915351</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/France/explor/LeHavreV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000354 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000354 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/France |area= LeHavreV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:12915351 |texte= [Biomarkers for toxicity and metabolic abnormalities of the main severe poisonings. Clinical and toxicologic symptoms. Conservative determination]. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:12915351" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a LeHavreV1
This area was generated with Dilib version V0.6.25. |